ArticleBMJ paediatrics open2025
Healthcare and productivity loss costs in young adults after bacterial meningitis: a cross-sectional follow-up study.
Article in BMJ paediatrics open, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectiveTo determine healthcare and productivity loss costs among young adult survivors of childhood bacterial meningitis (BM).
methodsIn this cross-sectional study, online versions of the Institute for Medical Technological Assessment (iMTA) Medical Consumption Questionnaire and the iMTA Productivity Costs Questionnaire were used to measure healthcare consumption and productivity loss costs in young adult survivors of childhood BM. Mean healthcare and productivity loss costs were calculated and the differences in costs across subgroups based on age at onset, sex and causative pathogens were investigated.
resultsA total of 454 patients were included in the cost analysis of healthcare utilisation and a total of 471 patients were included in the cost analysis of productivity losses. The 3-month mean societal cost per patient amounted to €4985.32 (median €1363.71, IQR €576.04-€2948.67), of which €4790.84 (median €1125.90, IQR €271.20-€2489.54) was due to productivity losses. Productivity loss costs were significantly higher in survivors of childhood BM caused by
conclusionsThis study highlights the potential significant economic burden in young survivors of childhood BM and emphasises the possible impact of very long-term sequelae. In particular, very long-term sequelae of BM contribute to indirect costs. To the best of our knowledge, this is the first study to investigate the societal costs of childhood BM over a two-decade follow-up period. Further research into societal costs in young adult survivors of neonatal meningitis is needed to provide additional insights into the economic burden of childhood BM.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.